After decades of growing pains, Medicare Advantage continues to expand no matter the political party of the sitting president, but how much growth and whom that growth most benefits — consumer or insurer — depends on which policy levers that administration pulls.
That’s the title of a new NEJM Perspective by Michael Chernew and me. After crunching the numbers, our argument is that for long term cost
Howard Gleckman noting some options given the demise of CLASS. He highlights several key points: Long term care needs aren’t going away so we have
At KHN, Susan Jaffe reports: A provision of the 2010 federal health law seeking to increase Medicare beneficiaries’ share of health care costs is meeting
Joe Lieberman has a few ideas about how to fix Medicare, as expressed in a Washington Post op-ed yesterday. They are, in brief: Raising the
In 2006 stand-alone prescription drug plans (PDPs) became a new source for prescription drug coverage for Medicare beneficiaries. PDPs weren’t just new to Medicare, they were
This post originally appeared on The Finance Buff. In my recent three-post series on Medicare’s structure and payment systems (part I, part II, part III),
A long-ish post on a very important issue. Quick review: Under competitive bidding among Medicare plans, private health insurers and traditional Medicare would offer bids
Aaron and my posts are starting to go up on Ezra Klein’s blog, where we’ll be all week. You should be reading them there. (Seriously,
On Saturday, the New York Times ran a story about an issue that has been (mostly) quietly simmering with little attention from the popular press:
I’m trying not to get swept up in the periodic frenzy that seizes the media every time HHS releases new information about exchange enrollment. The
Indianapolis has been pretty much shut down this week by weather. A retreat I was supposed to attend was cancelled today, giving me the unexpected
the health services research blog
Work posted here under copyright © of the authors • Details on the Site Policies page
